[1] |
Yan Haiyan, Ding Yankui, JiaHongjing , WangJiyuan , Zhang Xuewei, Hu Yinjie, Chu Junjie, Hu Hongyan, Guo Gaofeng.
Correlation of pre-hospital heparinization combined with one pack of drugs and revascularization in patients with acute ST-segment elevation myocardial infarction
[J]. Clinical Focus, 2023, 38(3): 232-236.
|
[2] |
Wang Jiaqi, Gao Man, Zhang Feifei, Li Yingxiao, Dang Yi, Qi Xiaoyong.
Predicting value of neutrophil to lymphocyte ratio combined with GRACE score on in-hospital major adverse cardiovascular events of postoperative PCI in acute STEMI patients
[J]. Clinical Focus, 2022, 37(5): 412-417.
|
[3] |
Deng Kaibin, Han Liang, Niu Shaoqian, Wang Haiyan, Wang Yanbo, Fu Yang, Wang Qing, Zhan Yang, Fu Xianghua.
Effect of optimized treatment approach on acute STEMI patients under the situation of prevention and control of COVID-19
[J]. Clinical Focus, 2021, 36(7): 595-599.
|
[4] |
Shi Jun, Liu Xinbing, Bai Yanyan, Yue Dandan, Wang Xiaoqing, Liu Tianhua, Feng Liuliu.
Influencing factors of myocardial microcirculation perfusion disorder after percutaneous coronary intervention in acute myocardial infarction and relationship with lactic acid
[J]. Clinical Focus, 2021, 36(5): 402-407.
|
[5] |
Zhou Jing, Dai Yunlang.
Clinical characteristics and prognosis of patients with isolated left main stenosis in coronary intervention
[J]. Clinical Focus, 2021, 36(1): 12-15.
|
[6] |
Sun Wei.
Prediction of no reflow phenomenon in patients with acute myocardial infarction undergoing coronary intervention by CHA2DS2VASc score
[J]. Clinical Focus, 2020, 35(9): 792-795.
|
[7] |
Su Yongcai, Zhang Xiaole, Huang Zhifeng, Feng Xinwu, Su Liangxian.
Clinical analysis of interventional therapy in patients with acute ST segment elevation myocardial infarction in hyperacute stage
[J]. Clinical Focus, 2020, 35(6): 513-516.
|
[8] |
Li Sixue, Gu Guoqiang, Liu Demin, Wang Qian, Zhang Guangming, Cui Wei.
Monocyte to highdensity lipoprotein cholesterol ratio can not predict contrast induced nephropathy in patients after PCI
[J]. Clinical Focus, 2020, 35(4): 307-311.
|
[9] |
Cao Wancai1, Cao Honglei2, Zhou Guo1,Dong Zhaoqiang3.
Treating hypertrophic obstructive cardiomyopathy with percutaneous transluminal septal myocardiam ablation via a transradial approach
[J]. Clinical Focus, 2020, 35(3): 216-220.
|
[10] |
Wang Haiyan1, Tian Li1, Zhao Ying2, Li Zhijuan1, Shi Jianping1, Fu Xianghua3.
Effects of early heparin therapy on patients with acute STsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention
[J]. Clinical Focus, 2020, 35(2): 134-138.
|
[11] |
Luo Kaifeng, Feng Chuanjie.
The factors influencing the prognosis of STsegment elevation myocardial infarction after coronary intervention A meta analysis
[J]. Clinical Focus, 2020, 35(12): 1067-1077.
|
[12] |
Wang Li1, Yu Tao2.
Analysis of influencing factors of in stent restenosis after percutaneous coronary intervention in patients with coronary heart disease
[J]. Clinical Focus, 2018, 33(8): 675-677,682.
|
[13] |
Wei Zhenheng, Zhang Juntang.
PCI preoperative single load dose and conventional dose risuvastatin on prognosis of patients with coronary heart disease
[J]. Clinical Focus, 2018, 33(6): 494-497.
|
[14] |
Liu Xiaoyu,Jia Guowei,Sun Rongguo,Ma Bocong,Zhao Ming,Zhang Hongbin,Zhang Wei.
Ticagrelor and clopidogrel on PCI perioperative hsCRP in patients with acute coronary syndrome
[J]. Clinical Focus, 2017, 32(5): 421-424.
|
[15] |
Qiao Xingke, Shi Yunqi, Wang Yongxin, Li Zhanquan, Hou Aijie.
Prediction of transforming growth factor β1 for instent restenosis in patients with coronary artery disease after percutaneous coronary intervention procedure
[J]. Clinical Focus, 2017, 32(3): 220-223.
|